Two B1 and B2 bradykinin receptor antagonists fail to inhibit the Ca2+ response elicited by bradykinin in human skin fibroblasts

General Pharmacology

Volumn 32, Issue 2, 1999, Pages 239-244

  Cassano, Giuseppe ^a   Susca, Francesco ^a   Lippe, Claudio ^a   Guanti, Ginevra ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Bradykinin analogs and derivatives; Bradykinin antagonists and inhibitors; Bradykinin pharmacology; Bradykinin physiology; Calcium physiology

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIUM; ICATIBANT; KALLIDIN[1-9]; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; DRUG DERIVATIVE; KALLIDIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SKIN FIBROBLAST; ADOLESCENT; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; METABOLISM; SKIN;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; BRADYKININ; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; KALLIDIN; MALE; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; SKIN;

EID: 0032587340     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00275-4     Document Type: Article

References (20)

1. Burch R.M., Axelrod J. Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblast. evidence for G protein regulation of phospholipase A2 Proc Natl Acad Sci USA. 84:1987;6374-6378.
2. 2+ stores. J Biol Chem. 267:1992;108-118.
3. 2+ elevation in cells from desmoid tumors. Oncol Rep. 3:1996;1161-1163.
4. Clapham D.E. Calcium signaling. Cell. 80:1995;259-268.
5. 9-bradykinin. J Biol Chem. 259:1984;9263-9268.
6. Hall J.M. Bradykinin receptors. Gen Pharmac. 28:1997;1-6.
7. Hess J.F., Borkowski J.A., Young G.S., Strader C.D., Ransom R.W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 184:1992;260-268.
8. 2+] with fluorescent indicators. Methods Cell Biol. 40:1994;155-181.
9. McAllister B., Leeb-Lundberg F., Olson M.S. Bradykinin inibition of EGF-and PDGF-induced DNA synthesis in human fibroblasts. Am J Physiol. 265:1993;C477-C484.
10. 2 bradykinin receptor. Proc Natl Acad Sci USA. 88:1991;7724-7728.
11. 1 bradykinin receptor. J Biol Chem. 269:1994;21583-21586.
12. 2 receptors in the respective control of cell growth and phospholipid hydrolysis Cancer Res. 52:1992;334-340.
13. Regoli D., Barabè J. Pharmacology of bradykinin and related kinins. Pharmac Rev. 32:1980;1-46.
14. Regoli D., Barabè J. Kinin receptors. Methods Enzymol. 163:1988;210-230.
15. 2 subtypes. Life Sci. 55:1994;735-749.
16. Rozengurt E. Neuropeptides as cellular growth factors. role of multiple signalling pathways Eur J Clin Invest. 21:1991;123-134.
17. Schroeder C., Beug H., Müller-Esterl W. Cloning and functional characterization of the ornithokinin receptor. J Biol Chem. 272:1997;12475-12481.
18. Slivka S.R., Insel P.A. Phorbol ester and neomycin dissociate bradykinin receptor-mediated arachidonic acid release and polyphosphoinositide hydrolysis in Madin-Darby canine kidney cells. J Biol Chem. 263:1988;14640-14647.
19. 2 bradykinin receptors. FASEB J. 3:1989;2019-2025.
20. Van Zoelen E., Peters P.H., Afink G.B., Van Gensen S., De Roos A.D., Van Rotterdam W., Theuvenet P.R. Bradykinin induced growth inhibition of normal rat kidney (NRK) cells is paralleled by a decrease in epidermal-growth-factor receptor expression. Biochem J. 298:1994;335-340.